The Corner Norbolsa | Cellnex is in talks to sell its 72% stake in its Swiss subsidiary to the investment arm of Manulife (a Canadian insurer), having put the sale on hold last year due to offers being too low. The Swiss unit is valued at around €2 billion, although negotiations are still ongoing and there is no guarantee that a deal will be finalised. This potential move forms part of Cellnex’s...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.